687
Views
17
CrossRef citations to date
0
Altmetric
Drug Evaluation

Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives

, MD, , MD MRCP(UK) & , MD FACP (Sanford I. Weill Professor of Metabolic Research, Medical Director)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alexander J Rodriguez, Claudio A Mastronardi & Gilberto J Paz-Filho. (2015) New advances in the treatment of generalized lipodystrophy: role of metreleptin. Therapeutics and Clinical Risk Management 11, pages 1391-1400.
Read now

Articles from other publishers (16)

Mohamed E. Elrggal, Ahmed Elkeraie, Sol Carriazo, Hany Sawaf, Si Yuan Khor, Yasmine Elkeraie, Issa Haddad, Khaled Moustafa & Mohamed Hassanein. 2023. Frontiers in Clinical Drug Research-Diabetes and Obesity: Volume 7. Frontiers in Clinical Drug Research-Diabetes and Obesity: Volume 7 168 207 .
Kai‐Wen Zhang, Yuan Jia, Yue‐Yue Li, Dan‐Yang Guo, Xiao‐Xiao Li, Kai Hu, Xiao‐Xi Qian, Zhong‐Hua Chen, Jun‐Jie Wu, Zheng‐Dong Yuan & Feng‐Lai Yuan. (2022) LEP and LEPR are possibly a double‐edged sword for wound healing. Journal of Cellular Physiology 238:2, pages 355-365.
Crossref
Francesca Mainieri, Veronica Maria Tagi & Francesco Chiarelli. (2022) Treatment Options for Lipodystrophy in Children. Frontiers in Endocrinology 13.
Crossref
Yue Peng, Qianyu Tang, Fan Xiao & Nian Fu. (2022) Regulation of Lipid Metabolism by Lamin in Mutation-Related Diseases. Frontiers in Pharmacology 13.
Crossref
João V. S. Guerra, Marieli M. G. Dias, Anna J. V. C. Brilhante, Maiara F. Terra, Marta García-Arévalo & Ana Carolina M. Figueira. (2021) Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases. Nutrients 13:8, pages 2830.
Crossref
Young Jin Tak & Sang Yeoup Lee. (2021) Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?. Current Obesity Reports 10:1, pages 14-30.
Crossref
Boris RosinTareq Jaouni. (2020) CASE REPORT OF SEVERE PROLIFERATIVE RETINOPATHY IN A PATIENT WITH CONGENITAL LIPODYSTROPHY. RETINAL Cases & Brief Reports 14:1, pages 69-71.
Crossref
Shinji Takeyari, Satoshi Takakuwa, Kei Miyata, Kenichi Yamamoto, Hirofumi Nakayama, Yasuhisa Ohata, Makoto Fujiwara, Taichi Kitaoka, Takuo Kubota, Noriyuki Namba, Norio Sakai & Keiichi Ozono. (2019) Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4): a case report. Clinical Pediatric Endocrinology 28:1, pages 1-7.
Crossref
Michael Rosenbaum & Rudolph L. Leibel. (2018) Physiological responses to leptin levels in lipodystrophy: a model for other hypoleptinemias?. Journal of Clinical Investigation 128:8, pages 3237-3239.
Crossref
Vera Francisco, Jesús Pino, Victor Campos-Cabaleiro, Clara Ruiz-Fernández, Antonio Mera, Miguel A. Gonzalez-Gay, Rodolfo Gómez & Oreste Gualillo. (2018) Obesity, Fat Mass and Immune System: Role for Leptin. Frontiers in Physiology 9.
Crossref
Michaela Gebauer & Arne Skerra. (2018) Prospects of PASylation® for the design of protein and peptide therapeutics with extended half-life and enhanced action. Bioorganic & Medicinal Chemistry 26:10, pages 2882-2887.
Crossref
Gitanjali Srivastava & Caroline Apovian. (2018) Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon. Current Obesity Reports 7:2, pages 147-161.
Crossref
Laura Papendieck & María B. Araujo. (2018) Clinical outcome in a series of pediatric patients with congenital generalized lipodystrophies treated with dietary therapy. Journal of Pediatric Endocrinology and Metabolism 31:1, pages 77-83.
Crossref
Uli Binder & Arne Skerra. (2017) PASylation®: A versatile technology to extend drug delivery. Current Opinion in Colloid & Interface Science 31, pages 10-17.
Crossref
Vanessa Abella, Morena Scotece, Javier Conde, Jesús Pino, Miguel Angel Gonzalez-Gay, Juan J. Gómez-Reino, Antonio Mera, Francisca Lago, Rodolfo Gómez & Oreste Gualillo. (2017) Leptin in the interplay of inflammation, metabolism and immune system disorders. Nature Reviews Rheumatology 13:2, pages 100-109.
Crossref
Renato Pasquali, Evanthia Diamanti-Kandarakis & Alessandra Gambineri. (2016) MANAGEMENT OF ENDOCRINE DISEASE: Secondary polycystic ovary syndrome: theoretical and practical aspects. European Journal of Endocrinology 175:4, pages R157-R169.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.